Literature DB >> 23281820

Rapamycin enhances TNF-α-induced secretion of IL-6 and IL-8 through suppressing PDCD4 degradation in orbital fibroblasts.

Won-Mo Lee1, Ji-Sun Paik, Won-Kyung Cho, Eun-Hye Oh, Seong-Beom Lee, Suk-Woo Yang.   

Abstract

PURPOSE: To investigate the effects of rapamycin on the TNF-α-induced secretion of interleukin-6 (IL-6) and IL-8 in orbital fibroblasts and its possible mechanism.
MATERIALS AND METHODS: Orbital fibroblasts were obtained from patients with thyroid-associated ophthalmopathy. IL-6 and IL-8 levels were measured by enzyme-linked immunosorbent assays. The down-regulation of PDCD4 was performed by PDCD4 siRNA transfection.
RESULTS: Rapamycin significantly enhanced TNF-α-induced IL-6 and IL-8 secretion from orbital fibroblasts. Down-regulation of PDCD4 by PDCD4 siRNA transfection reduced TNF-α-induced IL-6 and IL-8 secretion from orbital fibroblasts. In addition, TNF-α was found to promote the mTOR-dependent proteasome-mediated degradation of PDCD4. Rapamycin increased PDCD4 expression via the inhibition of TNF-α-induced PDCD4 degradation in orbital fibroblasts.
CONCLUSION: Rapamycin enhances the TNF-α-induced secretion of IL-6 and IL-8 by suppressing PDCD4 degradation in orbital fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23281820     DOI: 10.3109/02713683.2012.750368

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  9 in total

1.  Rapamycin reduces fibroblast proliferation without causing quiescence and induces STAT5A/B-mediated cytokine production.

Authors:  Zoe E Gillespie; Kimberly MacKay; Michelle Sander; Brett Trost; Wojciech Dawicki; Aruna Wickramarathna; John Gordon; Mark Eramian; Ian R Kill; Joanna M Bridger; Anthony Kusalik; Jennifer A Mitchell; Christopher H Eskiw
Journal:  Nucleus       Date:  2015       Impact factor: 4.197

Review 2.  The Role and Interactions of Programmed Cell Death 4 and its Regulation by microRNA in Transformed Cells of the Gastrointestinal Tract.

Authors:  William Frank Ferris
Journal:  Front Oncol       Date:  2022-06-29       Impact factor: 5.738

3.  Altered microRNA expression profiles in lung damage induced by nanosized SiO2.

Authors:  Hong Yang; Yingjian Zhang; Wenchao Li; Canshan Lao; Mingyue Li; Yi Zheng
Journal:  Bioengineered       Date:  2016-09-30       Impact factor: 3.269

4.  MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy.

Authors:  Bo-ding Tong; Man-Yi Xiao; Jie-Xi Zeng; Wei Xiong
Journal:  Mol Vis       Date:  2015-03-30       Impact factor: 2.367

Review 5.  Better Living through Chemistry: Caloric Restriction (CR) and CR Mimetics Alter Genome Function to Promote Increased Health and Lifespan.

Authors:  Zoe E Gillespie; Joshua Pickering; Christopher H Eskiw
Journal:  Front Genet       Date:  2016-08-18       Impact factor: 4.599

6.  Integrative Analysis of Proteomics and DNA Methylation in Orbital Fibroblasts From Graves' Ophthalmopathy.

Authors:  Sita Virakul; Poorichaya Somparn; Trairak Pisitkun; Peter J van der Spek; Virgil A S H Dalm; Dion Paridaens; P Martin van Hagen; Nattiya Hirankarn; Tanapat Palaga; Willem A Dik
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-15       Impact factor: 5.555

7.  The brain targeted delivery of programmed cell death 4 specific siRNA protects mice from CRS-induced depressive behavior.

Authors:  Yufeng Jia; Xiao Zhuang; Yi Zhang; Ming Zhao; Nuo Chen; Wen Li; Faliang Zhu; Chun Guo; Yan Li; Qun Wang; Yuan Li; Lining Zhang
Journal:  Cell Death Dis       Date:  2021-11-12       Impact factor: 8.469

8.  Construction of the coexpression network involved in the pathogenesis of thyroid eye disease via bioinformatics analysis.

Authors:  Jinxing Hu; Shan Zhou; Weiying Guo
Journal:  Hum Genomics       Date:  2022-09-08       Impact factor: 6.481

9.  The Effect of (-)-Epigallocatechin-3-Gallate on IL-1β Induced IL-8 Expression in Orbital Fibroblast from Patients with Thyroid-Associated Ophthalmopathy.

Authors:  Ji-Young Lee; Ji-Sun Paik; Mihee Yun; Seong-Beom Lee; Suk-Woo Yang
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.